Intracellular Th (ITCI) has had the highest return since January 1, 2025 and this year by a large-cap US stock, returning 50.9%.
| ASSET | % RETURN |
|---|---|
Intracellular Th (ITCI) | 50.9% |
Robinhood Markets (HOOD) | 37.52% |
Constellation Energy (CEG) | 36.3% |
Twilio (TWLO) | 35.42% |
Xpeng (XPEV) | 34.57% |
Nu (NU) | 29.6% |
CVS Health (CVS) | 27.56% |
Futu (FUTU) | 27.34% |
Vistra Energy (VST) | 26.26% |
AngloGold Ashanti (AU) | 26.18% |
Gold Fields Ltd ADR (GFI) | 25.31% |
Guidewire Software (GWRE) | 24.47% |
Summit Therapeutics (SMMT) | 24.43% |
Banco Bilbao Viscaya Argentaria SA ADR (BBVA) | 24.34% |
BeiGene (ONC) | 24.32% |
JD Inc Adr (JD) | 23.97% |
VF (VFC) | 23.93% |
Royalty Pharma (RPRX) | 23.64% |
Interactive Brokers (IBKR) | 23.42% |
Symbotic (SYM) | 23.38% |
Celestica (CLS) | 22.97% |
Arm Holdings plc American Depositary Shares (ARM) | 22.59% |
CAVA (CAVA) | 22.55% |
Sprouts Farmers Market LLC (SFM) | 22.54% |
Plains All American Pipeline (PAA) | 22.5% |
Large-cap stocks are treated as having a market cap of $10B+.
